lobbying_activities: 3232736
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3232736 | 5cbe8be5-b956-47ee-a2df-a22c0025b1e0 | Q3 | RED+BLUE STRATEGIES | 400693064 | DAVITA INC. | 2024 | third_quarter | MMM | H. R. 9747 - Continuing Appropriations and Extensions Act, 2025 - Issues related to funding government departments and agencies responsible for administering programs that support Medicare, Medicaid and Marketplace health care coverage for people with ESRD. Rules and Regulations focused on the inclusion of certain oral medications in the ESRD Medicare bundle. H.R. 6860 - Restore Protections for Dialysis Patients Act of 2023 - Support for policies that allow people with ESRD and their families to more readily maintain their dialysis and health care coverage through their employers. Support for CMS guidance encouraging innovative models to advance health care coverage for people living with ESRD. Issues related to health care workforce shortages impacting the ability to support the care of people living with End Stage Renal Disease. Issues related to the treatment of medications necessary for dialysis patients. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2024-10-05T13:06:00-04:00 |